What is the risk of developing an intracranial or intraparenchymal aneurysm in patients with coronary artery disease caused by systemic atherosclerosis? | Rounds What is the risk of developing an intracranial or intraparenchymal aneurysm in patients with coronary artery disease caused by systemic atherosclerosis? | Rounds
Loading...

What is the risk of developing an intracranial or intraparenchymal aneurysm in patients with coronary artery disease caused by systemic atherosclerosis?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Intracranial aneurysm risk in coronary artery disease with systemic atherosclerosis

Direct data quantifying the incidence (new-onset risk) of intracranial or intraparenchymal aneurysms specifically in patients with coronary artery disease (CAD) are not available from the retrieved literature. [1]

Available evidence on atherosclerotic burden and aneurysm risk

A retrospective case-control study using abdominal imaging-derived atherosclerotic burden found that higher abdominal aortic calcification index (ACI) was associated with increased risk of ruptured intracranial aneurysm compared with matched controls without intracranial aneurysm. [1]

Quantified association with aneurysm rupture

For ruptured intracranial aneurysm, each increment in ACI increased odds by OR 1.02 (95% CI 1.01–1.03) versus matched controls. [1]

For ruptured intracranial aneurysm, ACI greater than 3 increased odds by OR 5.77 (95% CI 3.29–10.11) versus matched controls. [1]

Evidence regarding coexisting coronary artery disease

In the same study, a history of coronary artery disease was reported to be less frequent in ruptured intracranial aneurysm cases compared with matched controls. [1]

Data gap for “development” of aneurysms

No retrieved study provided an incidence rate or prospective estimate for developing intracranial or intraparenchymal aneurysms over time in a CAD population. [1]

Related Questions